【K1 0111 交流专区】企文科技

icy97

Type	Announcement
Subject	OTHERS
Description	Medical Device Authority ("MDA") of Malaysia Grants Approval To K-One MediTech Sdn Bhd To Distribute Silicone Adhesive Tape Primarily Used For Wound Care Dressing
1. Introduction The Board of Directors of K-One Technology Berhad (“K-One Tech” or ‘Company” or “K-One Group”) wishes to announce that the Company’s wholly-owned subsidiary, K-One MediTech Sdn Bhd (“K-One MediTech”) has on 27 September 2022 received approval from the Medical Device Authority (“MDA”) under the Ministry of Health, Malaysia to distribute and sell silicone adhesive tapes primarily used for wound care dressing. The K-One Group will sell the silicone adhesive tapes in Malaysia as an authorized representative of Wuhan Huawei Technology Co., Ltd (“WH Tech”) which is the manufacturer based in China. 2. About WH Tech & K-One MediTech 2.1   WH Tech WH Tech, the developer and manufacturer of the silicone adhesive tapes is based in Wuhan, Hubei, China. It specializes in developing, manufacturing and marketing of various advanced wound dressings and other medical products. Since its establishment in 2002, WH Tech has been accorded with ISO 9001, ISO 13485, FDA and CE certifications. 2.2  K-One MediTech K-One MediTech is a wholly-owned subsidiary of K-One Tech. It was incorporated in 2001. Its principal business and focus are in the development, manufacturing and supply of medical and healthcare products which includes medical devices, healthcare consumables, oral care gadgets and hospital equipment. 3.  Silicone Adhesive Tapes For Wound Care Applications & MDA Approval The silicone adhesive tapes are advanced wound dressings which come in three product types. The first two product categories are applicable to a variety of indwelling catheters, electrodes or other external fixations that require gentle but robust skin protection and adhesion, while the third product type helps to improve scar appearance (including hypertrophic and keloid) and restores skin to a more natural color and texture. It also alleviates itchy skin and discomfort associated with scars. MDA has approved the distribution and sale of the above silicone adhesive tapes in three product categories for a period of five years from 26 September 2022 to 25 September 2027. The approval will provide the opportunity for the K-One Group to further expand its medical device business. The silicone adhesive tape wound dressing market is growing as its demand is anticipated to increase in tandem with the rising trend of surgeries performed in Malaysia (and abroad). Moreover, increasing awareness relating to the employment of medical tapes for securement among physicians and patients and the rising incidence of wounds, burns, injuries are anticipated to spice up the market demand. 4. Financial Effects The approval will have immaterial impact on the net assets and gearing of K-One Tech for the financial year ending 31 December 2022. It will not have any effect on the issued and paid-up share capital and the substantial shareholders’ shareholding in K-One Tech. With the distribution and marketing process anticipated to commence immediately and sales progressively scaling up in the coming years, it is expected to contribute positively to the earnings of K-One Tech for the financial years ending 31 December 2022 and beyond. 5. Risk Factors The import and distribution of the said silicone adhesive tapes will be subjected to various risks which include supply chain disruptions, pricing changes, market demand volatility, competition and currency rates fluctuation. Notwithstanding, the K-One Group has established a successful track record in undertaking manufacturing and distribution of medical devices which would help in mitigating such risks.   6. Approvals Required The distribution and sales of the said silicone adhesive tapes for wound care dressing do not require approval from the shareholders of K-One Tech or relevant authorities except MDA which it has received the necessary approval. 7. Directors’ Statement The Board of K-One Tech is of the opinion that the distribution and supply of the said silicone adhesive tapes primarily for wound care applications is in the best interest of the K-One Group after considering its potential and synergy to its existing healthcare business segment. This announcement is dated 28 September 2022.

icy97

Type	Announcement
Subject	OTHERS
Description	MEDICAL DEVICE AUTHORITY (MDA) OF MALAYSIA GRANTS REGISTRATION APPROVAL TO K-ONE MEDITECH SDN BHD TO DISTRIBUTE DIVERSEY'S DISINFECTANT WIPES USED FOR CLEANING SURFACES AND EQUIPMENT
The Board of Directors of K-One Technology Berhad (“K-One Tech” or ‘Company” or “K-One Group”) wishes to announce that the Company’s wholly-owned subsidiary, K-One MediTech Sdn Bhd (“K-One MediTech”) has on 30 August 2023 received approval from the Medical Device Authority (“MDA”) under the Ministry of Health, Malaysia for registration of Diversey’s Oxivir Excel disinfectant wipes (“wipes”) used for cleaning surfaces and equipment to be distributed in Malaysia. The K-One Group will sell the wipes in Malaysia as the exclusive distributor of Diversey (Malaysia) Sdn Bhd (“Diversey”).   Please refer to the attachment for details of the announcement. This announcement is dated 1 September 2023.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3382677

Attachments MDA approval of Wipes.pdf

icy97

Type	Announcement
Subject	OTHERS
Description	K-ONE TECHNOLOGY BERHAD ("K-ONE" OR THE "COMPANY")PROPOSED DIVERSIFICATION
On behalf of the Board of Directors of K-One ("Board"), UOB Kay Hian Securities (M) Sdn Bhd ("UOBKH") wishes to announce that the Company intends to undertake the proposed diversification of the existing business of K-One and its subsidiaries ("K-One Group" or the "Group") to include the distribution and sale of healthcare products ("Healthcare Products Business") ("Proposed Diversification"). Further details of the Proposed Diversification are set out in the attachment. This announcement is dated 1 April 2024.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3435433

Attachments K-One - Announcement.pdf

icy97

SUMMARY OF KEY FINANCIAL INFORMATION 30 Jun 2024

		INDIVIDUAL PERIOD		CUMULATIVE PERIOD
		CURRENT YEAR QUARTER	PRECEDING YEAR CORRESPONDING QUARTER	CURRENT YEAR TO DATE	PRECEDING YEAR CORRESPONDING PERIOD
		30 Jun 2024	30 Jun 2023	30 Jun 2024	30 Jun 2023
		$$'000	$$'000	$$'000	$$'000

1	Revenue	44,754	43,214	89,645	84,161
2	Profit/(loss) before tax	1,219	366	3,518	138
3	Profit/(loss) for the period	1,079	18	2,764	-407
4	Profit/(loss) attributable to ordinary equity holders of the parent	1,008	18	2,831	-407
5	Basic earnings/(loss) per share (Subunit)	0.12	0.00	0.34	-0.05
6	Proposed/Declared dividend per share (Subunit)	0.00	0.00	0.00	0.00
		AS AT END OF CURRENT QUARTER		AS AT PRECEDING FINANCIAL YEAR END
7	Net assets per share attributable to ordinary equity holders of the parent ($$)	0.1434		0.1400

icy97

Type	Announcement
Subject	TRANSACTIONS (CHAPTER 10 OF LISTING REQUIREMENTS) RELATED PARTY TRANSACTIONS
Description	K-ONE TECHNOLOGY BERHAD ("K-ONE" OR "COMPANY")- PURCHASE OF FACTORY FROM LIM BENG FOOK/LIM SOON SENG BY K-ONE MEDITECH SDN BHD, A WHOLLY-OWNED SUBSIDIARY OF K-ONE TECHNOLOGY BHD.
Pursuant to Rule 10.08(1) of the ACE Marketing Listing Requirements of Bursa Malaysia Securities Berhad, the Board of Directors of K-One Technology Bhd (“K-One” or “Company”) wishes to announce that its wholly-owned subsidiary, K-One MediTech Sdn. Bhd. (“K-One MediTech”) has on 4 October 2024 entered into a Sale and Purchase Agreement (“SPA”) with related parties, namely Lim Beng Fook and Lim Soon Seng for the purchase of a piece of leasehold land together with a one (1) unit of two (2) storey detached factory erected thereon bearing postal address 68, Lengkok Rishah 2, Kawasan Perindustrian Silibin, 30100 Ipoh, Perak for a total consideration of RM3,000,000.00 ("the Purchase"). The Purchase is a related party transaction as Lim Beng Fook and Lim Soon Seng who are the Executive Chairman and CEO of K-One respectively are the related parties and are interested in the Purchase. Please refer to the attachment for further details. This announcement is dated 4 October 2024.

https://www.bursamalaysia.com/market_information/announcements/company_announcement/announcement_details?ann_id=3489310

Attachments K-One - RPT announcement.pdf